These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37171467)

  • 1. Patient-reported outcomes for older adults on CamAPS FX closed loop system.
    Schneider-Utaka AK; Hanes S; Boughton CK; Hartnell S; Thabit H; Mubita WM; Draxlbauer K; Poettler T; Hayes J; Wilinska ME; Mader JK; Narendran P; Leelarathna L; Evans ML; Hovorka R; Hood KK
    Diabet Med; 2023 Sep; 40(9):e15126. PubMed ID: 37171467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents.
    Hood KK; Garcia-Willingham N; Hanes S; Tanenbaum ML; Ware J; Boughton CK; Allen JM; Wilinska ME; Tauschmann M; Denvir L; Thankamony A; Campbell F; Wadwa RP; Buckingham BA; Davis N; DiMeglio LA; Mauras N; Besser REJ; Ghatak A; Weinzimer SA; Fox DS; Kanapka L; Kollman C; Sibayan J; Beck RW; Hovorka R;
    Diabetes Obes Metab; 2022 Dec; 24(12):2309-2318. PubMed ID: 35837984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study.
    Boughton CK; Hartnell S; Thabit H; Mubita WM; Draxlbauer K; Poettler T; Wilinska ME; Hood KK; Mader JK; Narendran P; Leelarathna L; Evans ML; Hovorka R
    Lancet Healthy Longev; 2022 Mar; 3(3):e135-e142. PubMed ID: 35359882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
    Thabit H; Boughton C; Mubita W; Rubio J; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Gregory AM; Hovorka R; Rutter MK
    Diabetes Obes Metab; 2023 Mar; 25(3):889-893. PubMed ID: 36335565
    [No Abstract]   [Full Text] [Related]  

  • 5. Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial.
    Kubilay E; Trawley S; Ward GM; Fourlanos S; Grills CA; Lee MH; MacIsaac RJ; O'Neal DN; O'Regan NA; Sundararajan V; Vogrin S; Colman PG; McAuley SA
    Diabet Med; 2023 Apr; 40(4):e15020. PubMed ID: 36468784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
    Boughton CK; Hartnell S; Thabit H; Poettler T; Herzig D; Wilinska ME; Ashcroft NL; Sibayan J; Cohen N; Calhoun P; Bally L; Mader JK; Evans M; Leelarathna L; Hovorka R
    Diabetes Obes Metab; 2021 Jun; 23(6):1389-1396. PubMed ID: 33606901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.
    Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial.
    Ware J; Boughton CK; Allen JM; Wilinska ME; Tauschmann M; Denvir L; Thankamony A; Campbell FM; Wadwa RP; Buckingham BA; Davis N; DiMeglio LA; Mauras N; Besser REJ; Ghatak A; Weinzimer SA; Hood KK; Fox DS; Kanapka L; Kollman C; Sibayan J; Beck RW; Hovorka R;
    Lancet Digit Health; 2022 Apr; 4(4):e245-e255. PubMed ID: 35272971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.
    McAuley SA; Trawley S; Vogrin S; Ward GM; Fourlanos S; Grills CA; Lee MH; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; Colman PG; MacIsaac RJ
    Diabetes Care; 2022 Feb; 45(2):381-390. PubMed ID: 34844995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.
    Wheeler BJ; Collyns OJ; Meier RA; Betts ZL; Frampton C; Frewen CM; Galland B; Hewapathirana NM; Jones SD; Chan DSH; Roy A; Grosman B; Kurtz N; Shin J; Vigersky RA; de Bock MI
    Acta Diabetol; 2022 Jan; 59(1):31-37. PubMed ID: 34453208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world outcomes with different technology modalities in type 1 diabetes.
    Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
    Fuchs J; Allen JM; Boughton CK; Wilinska ME; Thankamony A; de Beaufort C; Campbell F; Yong J; Froehlich-Reiterer E; Mader JK; Hofer SE; Kapellen TM; Rami-Merhar B; Tauschmann M; Hood K; Kimbell B; Lawton J; Roze S; Sibayan J; Cohen N; Hovorka R;
    BMJ Open; 2021 Feb; 11(2):e042790. PubMed ID: 33579766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives.
    Hood KK; Laffel LM; Danne T; Nimri R; Weinzimer SA; Sibayan J; Bailey RJ; Schatz D; Bratina N; Bello R; Punel A; Calhoun P; Beck RW; Bergenstal RM; Phillip M
    Diabetes Technol Ther; 2021 Dec; 23(12):857-861. PubMed ID: 34270328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control.
    Cobry EC; Kanapka LG; Cengiz E; Carria L; Ekhlaspour L; Buckingham BA; Hood KK; Hsu LJ; Messer LH; Schoelwer MJ; Emory E; Ruedy KJ; Beck RW; Wadwa RP; Gonder-Frederick L;
    Diabetes Technol Ther; 2021 Jun; 23(6):401-409. PubMed ID: 33404325
    [No Abstract]   [Full Text] [Related]  

  • 16. Hybrid closed-loop therapy: Where are we in 2021?
    Leelarathna L; Choudhary P; Wilmot EG; Lumb A; Street T; Kar P; Ng SM
    Diabetes Obes Metab; 2021 Mar; 23(3):655-660. PubMed ID: 33269551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    Diabet Med; 2023 Feb; 40(2):e15015. PubMed ID: 36424877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial.
    Kudva YC; Laffel LM; Brown SA; Raghinaru D; Pinsker JE; Ekhlaspour L; Levy CJ; Messer LH; Kovatchev BP; Lum JW; Beck RW; Gonder-Frederick L;
    Diabetes Technol Ther; 2021 Oct; 23(10):673-683. PubMed ID: 34115959
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review.
    Speight J; Choudhary P; Wilmot EG; Hendrieckx C; Forde H; Cheung WY; Crabtree T; Millar B; Traviss-Turner G; Hill A; Ajjan RA
    Diabet Med; 2023 Jan; 40(1):e14944. PubMed ID: 36004676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.